Proinflammatory mediator pathway

The proinflammatory mediator pathway encompasses a complex network of signaling cascades and molecular interactions responsible for initiating and amplifying the inflammatory response (StatPearls, 2023). This pathway is triggered by various stimuli, including pathogens, tissue injury, or metabolic stress, leading to the production and release of signaling molecules such as cytokines (e.g., TNF, IL-1, IL-6), chemokines, and lipid mediators like prostaglandins (Nature Reviews Immunology, 2017). These mediators act on specific cell-surface receptors to activate intracellular signaling cascades, most notably the NF-κB and JAK-STAT pathways, which ultimately regulate the transcription of genes involved in immune cell recruitment and activation (PubMed, PMC4056575). While essential for host defense against pathogens and injury, dysregulation of this pathway is a hallmark of chronic inflammatory and autoimmune diseases, including rheumatoid arthritis, psoriasis, and inflammatory bowel disease (NIH, 2022). Therapeutic strategies often focus on inhibiting specific nodes within the pathway, using monoclonal antibodies to neutralize cytokines or small molecules to inhibit key enzymes like cyclooxygenase or Janus kinases (PubChem, 2024).

Other names

Inflammatory signaling pathwayPro-inflammatory cascadeCytokine signaling pathwayPro-inflammatory mediator network

Inhibition of proinflammatory cytokine activity, blockade of cytokine receptors, or inhibition of intracellular signaling enzymes and transcription factors involved in the inflammatory cascade.